https://www.marketscreener.com/quote/stock/NUGENEREX-IMMUNO-ONCOLOGY-120798005/news/Generex-Biotechnology-Corporation-and-Nugenerex-Immuno-Oncology-Grants-Licensing-Rights-to-Bintai-He-33605293/?utm_source=telegram&utm_medium=social&utm_campaign=share